ProQR Therapeutics
PRQR
PRQR
67 hedge funds and large institutions have $333M invested in ProQR Therapeutics in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 63 → 67 (+4)
2.11% more ownership
Funds ownership: 60.08% → 62.19% (+2.1%)
Holders
67
Holding in Top 10
–
Calls
$2.1M
Puts
$1.28M
Top Buyers
| 1 | +$10.8M | |
| 2 | +$4.14M | |
| 3 | +$2.99M | |
| 4 |
Millennium Management
New York
|
+$2.13M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$1.28M |
Top Sellers
| 1 | -$4.96M | |
| 2 | -$4.81M | |
| 3 | -$2.56M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.06M |
| 5 |
Morgan Stanley
New York
|
-$1.79M |